Aim: Hypothyroidism is a common clinical problem that is successfully treated with hormone substitutes in the form of levothyroxine (LT4). LT4 is a drug with a narrow therapeutic index and is usually administered by strict rules, standardly at least half an hour before breakfast. The aim of this study was to investigate a possible effect of different timings of administration on thyroid function status and lipid profile.

Methods: The study included patients with the diagnosis of primary hypothyroidism, which were using a stable dose of levothyroxine. They were randomized into three different groups regarding the timing of LT4 administration in a crossover fashion. Each timing regimen lasted for at least 8 weeks; timing regimen A-half an hour before breakfast; timing regimen B-an hour before the main meal of the day; timing regimen C-at bedtime (minimally 2 h after dinner). The hormones (TSH, fT3, fT4) and lipid profile (triglycerides, HDL-, LDL-, and total cholesterol) were measured before the study, at the beginning of every timing regimen and at the end of the study.

Results: Altogether, 84 patients finished the study. Different timings of LT4 administration were non-inferior in comparison to the standard one and between each other. Median differences in TSH level between baseline and timing regimens were: baseline vs. A = -0.017 95% C.I. (-0.400-0.192); baseline vs. B = -0.325 95% C.I. (-0.562-0.023); baseline vs. C = -0.260 95% C.I. (-0.475-0.000). There were no statistically significant differences in either TSH, fT4, or fT3 when compared between all three timing regimens of LT4 administration and the baseline. There were no statistically significant differences in any of the lipid profile parameters (triglycerides, HDL-, LDL-, and total cholesterol) when compared between all three timing regimens of LT4 administration and the baseline.

Conclusion: The three investigated timing regimens of LT4 administration were equally efficient and offer additional options regarding the treatment individualization.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12020-018-1686-1DOI Listing

Publication Analysis

Top Keywords

lt4 administration
20
timing regimen
20
timing regimens
16
regimens lt4
12
timing
11
hour breakfast
8
lipid profile
8
triglycerides hdl-
8
hdl- ldl-
8
ldl- total
8

Similar Publications

Article Synopsis
  • There is growing interest in using a combination of levothyroxine (LT4) and triiodothyronine (T3) to treat hypothyroidism, particularly for patients who still experience symptoms despite optimal LT4 treatment.
  • Although past randomized trials have not consistently shown clear benefits, guidelines suggest trying T3 with LT4 for patients who are symptomatic.
  • Recent trials suggest that the combination therapy is safe, with low reports of side effects related to overtreatment, which may encourage future uses of the LT4:T3 ratio around 15:1 in clinical practice.
View Article and Find Full Text PDF

Objective: To explore the impact of levothyroxine (L-T4) administration at different time points on pregnancy outcomes and offspring development in patients with subclinical hypothyroidism (SCH).

Methods: In this retrospective study, medical records of 107 patients with SCH treated in Huzhou Nanxun District People's Hospital from February 2021 to March 2023 were retrospectively reviewed. Of them, 55 patients received treatment before eight gestational weeks (Early group), and 52 patients received treatment after eight gestational weeks (Mid group).

View Article and Find Full Text PDF

Breakfast Habits in Patients Using Levothyroxine: Patient Experiences and Preferences.

J Endocr Soc

October 2024

Department of Internal Medicine, Zuyd Thyroid Center, Zuyderland Medical Center, 6162 BG Sittard-Geleen, the Netherlands.

Background: Levothyroxine (LT4) is recommended to be ingested in a fasting state, 30-60 minutes before breakfast to avoid interactions with food and drugs. In clinical practice, we noticed that this instruction may be inconvenient for patients. Therefore, we aimed to evaluate patient experiences and preferences concerning the recommended fasting administration of LT4.

View Article and Find Full Text PDF

Oldie but Goldie: The Fundamental Role of Radioiodine in the Management of Thyroid Cancer.

J Clin Med

October 2024

Endocrinology Unit, Department of Human Pathology of Adulthood and Childhood DETEV, University of Messina, 98125 Messina, Italy.

Article Synopsis
  • Recent advancements in the management of differentiated thyroid cancer (DTC) emphasize the importance of careful postoperative disease assessment to determine if iodine-131 therapy is needed and to tailor treatment goals accordingly (ablative, adjuvant, or therapeutic).
  • A comprehensive review of the literature highlights that personalized risk-based approaches to iodine-131 therapy significantly enhance early disease staging and response assessment, particularly for metastatic DTC patients.
  • Diagnostic and theragnostic uses of iodine isotopes are crucial for improving postoperative risk stratification and enabling more effective evaluation of patient responses to initial treatments.
View Article and Find Full Text PDF

Systematic review of thyroid function in NKX2-1-related disorders: Treatment and follow-up.

PLoS One

October 2024

Department of Child Neurology, Movement Disorders Unit, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.

Article Synopsis
  • NKX2-1 is a critical transcription factor linked to rare disorders that cause thyroid, lung, and brain issues, with early diagnosis being key for effective treatment.
  • This systematic review analyzes the effectiveness of Levothyroxine (LT4) treatment for NKX2-1-related disorders, focusing on congenital hypothyroidism, treatment initiation, and dosage variations.
  • Findings reveal that congenital hypothyroidism is common in these patients, yet LT4 is initiated in only 10%, with significant reliance on age at diagnosis affecting treatment outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!